Investor Centre Ltd. (ICU)

Overview

SeaStar Medical Holding Corporation is a prominent medical device company based in the United States, specifically headquartered in Denver, Colorado. They are at the forefront of developing innovative platform therapies aimed at mitigating the impacts of hyperinflammation on critical organs. The company's core mission revolves around harnessing the body's natural inflammatory response to combat infections and facilitate the healing of damaged tissue. This focus positions SeaStar Medical as a key player in addressing complex medical conditions associated with excessive inflammation.

Products and Services

SeaStar Medical Holding Corporation is engaged in the development of cutting-edge products across various therapeutic areas. These include:

• Pediatric and Adult Acute Kidney Injury on CRRT: Developing treatments to address acute kidney injury (AKI) in both pediatric and adult patients undergoing Continuous Renal Replacement Therapy (CRRT), aiming to improve outcomes and recovery rates.
• Cardiorenal Syndrome in Congestive Heart Failure: Focusing on innovative solutions for patients suffering from cardiorenal syndrome, a condition that complicates congestive heart failure by affecting the heart and kidneys simultaneously, thereby enhancing patient care and management.
• Myocardial Stunning in End Stage Renal Disease: Working on therapies for myocardial stunning, a temporary reduction in the heart's pumping function occurring in patients with end-stage renal disease (ESRD), seeking to improve cardiac function and patient quality of life.
• Hepatorenal Syndrome: Developing treatments for hepatorenal syndrome, a severe condition that develops in patients with advanced liver disease and deteriorates kidney function, aiming to offer hope and new solutions for these critically ill patients.